Amy Shank discusses what the final standard MOU, sent to the FDA from the White House Office of Management and Budget is, what it does, how it works and what it means for your pharmacy.

Dylan Herr, RA/QA Development Manager at Eagle, understands that the revised USP <797> chapter for sterile compounding makes significant revisions to the old chapter. In this latest article, Dyan is happy to provide you with an overview of those changes and strategies for implementing them.